Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for Late-Life Generalized Anxiety Disorder
NCT00105586Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Dec 2004
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in generalized anxiety disorder (GAD), sponsored by University of Pittsburgh. Started Dec 2004; status: completed.
02
Drugs
escitalopram
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00105586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00105586.